Aviso Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.9M Buy
2,504
+749
+43% +$884K 0.1% 85
2026
Q2
$2.1M Buy
1,755
+263
+18% +$269K 0.07% 99
2026
Q1
$1.37M Buy
1,492
+170
+13% +$172K 0.05% 132
2025
Q4
$1.42M Buy
1,322
+83
+7% +$79.4K 0.05% 126
2025
Q3
$945K Buy
1,239
+1,236
+41,200% +$920K 0.04% 164
2025
Q2
$2.34K Buy
+3
New +$2.33K ﹤0.01% 327
2024
Q4
– Sell
-108
Closed -$95.7K – 376
2024
Q3
$95.7K Buy
108
+3
+3% +$2.7K ﹤0.01% 252
2024
Q2
$95.1K Buy
+105
New +$84K 0.01% 249

Other funds holding LLY

Aviso Financial's LLY Position: Q3 2026 in Review

Aviso Financial increased its Eli Lilly (LLY) stake by 43% in Q3 2026, buying an estimated $884K and bringing the position to 2,504 shares worth $2.9M. The position accounts for 0.1% of the portfolio, ranked #85.

Aviso Financial first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. 4,568 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Aviso Financial held 2,504 shares of Eli Lilly worth $2.9M as of Q3 2026.
  • Aviso Financial bought 749 Eli Lilly shares in Q3 2026, an estimated $884K.
  • Eli Lilly made up 0.1% of Aviso Financial's portfolio in Q3 2026, its #85 holding.
  • Aviso Financial first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • 4,568 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Aviso Financial's 13F filing for Q3 2026, filed 12 Nov 2026.